This inventor holds 1 USPTO granted patent. Top assignee: Biofermin Pharmaceutical Co., Ltd.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: The Innovations of Hideki Yamamura
Introduction
Hideki Yamamura is a notable inventor based in Hyogo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of enhancers for hypoglycemic effects. His work is characterized by a focus on improving the efficacy of existing treatments through innovative approaches.
Latest Patents
Yamamura holds a patent for a hypoglycemic effect enhancer. This invention enhances the activity of an α-glucosidase inhibitor and comprises at least one kind of bacteria selected from a group that includes bifidobacteria, lactic acid bacteria, saccharifying bacteria, and butyric acid bacteria. This patent represents a significant advancement in the management of blood sugar levels.
Career Highlights
Yamamura is currently associated with Biofermin Pharmaceutical Co., Ltd., where he continues to work on innovative solutions in the pharmaceutical industry. His dedication to research and development has positioned him as a key figure in his field.
Collaborations
Yamamura collaborates with esteemed colleagues, including Yasuhiro Isa and Masaki Shimakawa. Their combined expertise fosters a productive environment for innovation and development.
Conclusion
Hideki Yamamura's contributions to the field of pharmaceuticals, particularly through his patent for a hypoglycemic effect enhancer, highlight his role as an influential inventor. His ongoing work at Biofermin Pharmaceutical Co., Ltd. continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile